uMed: Clinical Research and Patient Data Platform
uMed helps pharmaceutical companies and healthcare researchers identify and recruit study participants using EMR-linked registries. It is designed for teams needing longitudinal data and rapid qualitative insights.
At a glance
- Category
- Healthcare
- Best for
- Pharmaceutical companies, Clinical Research Organizations (CROs), Healthcare researchers, Biotech firms, Medical device companies
- Pricing
- Pricing was not clearly available from the provided evidence. Buyers should confirm current pricing on the vendor website.
- Key use cases
- Participant Identification and Enrollment, Rapid Qualitative Research, Longitudinal Evidence Generation, Post-Market Safety Monitoring
- Official website
- umed.io
uMed is a clinical research platform designed to address evidence gaps in life science research. It connects researchers with a network of consented patients and verified clinical datasets to support data collection.
The platform is intended for pharmaceutical companies, clinical trial teams, and healthcare research institutions. It links electronic health records (EHR) with patient-reported outcomes to track participants over time.
Researchers can use the platform for various stages of drug development, including natural history characterization, trial design, and post-market safety monitoring. The system includes specialized cohorts for cardiometabolic, Parkinson's, and interstitial lung diseases.
Buyers should confirm how the remote recruitment and data collection workflows align with their specific regulatory requirements and if the available disease cohorts match their target patient populations.
Key Features
Prospectively recruited, EMR-linked registries designed to follow patients over time for longitudinal evidence.
Uses AI and automated tools to identify and enroll eligible participants based on clinical data.
A tool for rapid qualitative research designed to deliver patient data insights in under four weeks.
Supports continuous, AI-driven longitudinal evidence generation across the product lifecycle.
Links consented patient records with electronic health records to provide clinical history.
The platform is HIPAA-compliant and holds certifications including ISO27001 and ISO9001.
Use Cases
Identifying eligible trial patients through EHR-based screening and remote enrollment.
Gathering insights from verified patient cohorts to support commercial decisions or messaging.
Tracking disease progression and treatment response over time using linked clinical and patient data.
Supporting pharmacovigilance with linked EMR signal detection.
Best For
Pricing
Pricing was not clearly available from the provided evidence. Buyers should confirm current pricing on the vendor website.
FAQ
uMed provides a platform that connects consented patients with verified clinical datasets, using EMR-linked registries to help researchers generate real-world evidence.
Yes, the platform is HIPAA-compliant and is certified to ISO27001, ISO9001, Cyber Essentials Plus, and the NHS Digital Data & Security Toolkit.
SnapACCESS is designed for rapid qualitative research insights in under four weeks, while SpanACCESS is for continuous, longitudinal evidence generation over a longer period.
Source category: Healthcare
Source subcategory: Data Management
